MTCM
CLVS

Mint Tower Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Mint Tower Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,000
Closed -$21K – 313
2019
Q4 		$21K Hold
2,000
– – ﹤0.01% 219
2019
Q3 		$8K Buy
2,000
+100
+5% +$809 ﹤0.01% 175
2019
Q2 		$28K Buy
+1,900
New +$34.3K ﹤0.01% 229

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Mint Tower Capital Management's CLVS Position: Q1 2020 in Review

Mint Tower Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2020, closing a stake of 2,000 shares — an estimated $21K sold.

Mint Tower Capital Management first reported a position in CLVS in Q2 2019 and held it in 3 quarters. The position peaked at $28K in Q2 2019. 154 funds tracked by Wall St. Rank hold CLVS as of Q1 2020.

  • Mint Tower Capital Management reported no remaining Clovis Oncology, Inc. position as of Q1 2020 after selling out during the quarter.
  • Mint Tower Capital Management sold 2,000 Clovis Oncology, Inc. shares in Q1 2020, an estimated $21K.
  • Mint Tower Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2019 and held it in 3 quarters.
  • Mint Tower Capital Management's Clovis Oncology, Inc. position peaked at $28K in Q2 2019.
  • 154 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2020.

Based on Mint Tower Capital Management's 13F filing for Q1 2020, filed 13 May 2020.